Crossmark

Remnant cholesterol level modified the effects of intensive systolic blood pressure lowering treatment in high-risk hypertensive patients: a post hoc analysis of the ESPRIT trial

Crossref DOI link: https://doi.org/10.1038/s41440-026-02596-7

Published Online: 2026-04-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Haixu

Li, Shitian

Sun, Ying

Li, Yan

Bilige, Wuhan

Qi, Fengjun

Xie, Liying

Wu, Guanghan

Yan, Haiyan

Yang, Yanhua

Zhai, Xiaojuan

Luo, Xia

Guo, Anran

Niu, Wentang

Chen, Hairong

Ren, Yihui

Zhang, Xiaohan

Huang, Chunxia

Chen, Zuyi

Chen, Lichun

Zhang, Haibo

Li, Jing

Liu, Jiamin

Zheng, Xin
License Information

Text and Data Mining valid from 2026-04-21

Version of Record valid from 2026-04-21
More Information

Article History

Received: 6 December 2025

Revised: 7 February 2026

Accepted: 11 February 2026

First Online: 21 April 2026

Compliance with ethical standards

:

: JLi reports research grants from Servier (TIANJIN) Pharmaceutical for assessing effects of indapamide sustained release and perindopril amlodipine, to the Fuwai Hospital, and honoraria for presentation from Servier (TIANJIN) Pharmaceutical. All other authors report no competing interests.

Document is current

Any future updates will be listed below